YS Biopharma appoints new Directors
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
iSolveSM information on demand is the result of our focus on customer relationship
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions
The 200 bedded hospital owned & operated by Alexis
Additionally, an MoU was signed between the Dental Council of India and Quality Council of India for the assessment and rating of undergraduate dental colleges
KIMS has reported total income of Rs. 609.091 crores during the period ended December 31, 2023
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40
Subscribe To Our Newsletter & Stay Updated